The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Doherty, D. G.
Right arrow Articles by Nepom, G. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Doherty, D. G.
Right arrow Articles by Nepom, G. T.
The Journal of Immunology, 1998, 161: 3527-3535.
Copyright © 1998 by The American Association of Immunologists

Structural Basis of Specificity and Degeneracy of T Cell Recognition: Pluriallelic Restriction of T Cell Responses to a Peptide Antigen Involves Both Specific and Promiscuous Interactions Between the T Cell Receptor, Peptide, and HLA-DR1

Derek G. Doherty2,*, Julie E. Penzotti*,{dagger}, David M. Koelle{dagger},{ddagger}, William W. Kwok*, Terry P. Lybrand{dagger}, Susan Masewicz* and Gerald T. Nepom3,*,{dagger}

* Virginia Mason Research Center, {dagger} University of Washington School of Medicine, and {ddagger} Fred Hutchinson Cancer Research Center, Seattle, WA 98101

TCR engagement of peptide-MHC class II ligands involves specific contacts between the TCR and residues on both the MHC and peptide molecules. We have used molecular modeling and assays of peptide binding and T cell function to characterize these interactions for a CD4+ Th1 cell clone, ESL4.34, which recognizes a peptide epitope of the herpes simplex type 2 virus virion protein, VP16 393–405, in the context of several HLA-DR alleles. This clone responded to VP16 393–405 in proliferation and cytotoxicity assays when presented by DRB1*0402, DRB1*1102, and DRB1*1301, which share a common amino acid sequence, ILEDE, at residues 67–71 in the {alpha}-helical portion of the DRß polypeptide, but not when presented by other DR4, DR11, and DR13 alleles that are negative for this sequence. Using a panel of APCs expressing DR4 molecules that were mutagenized in vitro at individual residues within this shared epitope and using peptide analogues with single amino acid substitutions of predicted MHC and TCR contact residues, a unit of recognition was identified dependent on DRß residues 67–71 and relative position 4 (P4) of the VP16 393–405 peptide. The interactions of this portion of the peptide-DR ligand with the ESL4.34 TCR support a structural model for MHC-biased recognition in some Ag-specific and alloreactive T cell responses and suggest a possible mechanism for autoreactive T cell selection in rheumatoid arthritis.




This article has been cited by other articles:


Home page
J. Immunol.Home page
P. Kudela, B. Janjic, J. Fourcade, F. Castelli, P. Andrade, J. M. Kirkwood, T. El-Hefnawy, M. Amicosante, B. Maillere, and H. M. Zarour
Cross-Reactive CD4+ T Cells against One Immunodominant Tumor-Derived Epitope in Melanoma Patients
J. Immunol., December 1, 2007; 179(11): 7932 - 7940.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Sospedra, P. A. Muraro, I. Stefanova, Y. Zhao, K. Chung, Y. Li, M. Giulianotti, R. Simon, R. Mariuzza, C. Pinilla, et al.
Redundancy in Antigen-Presenting Function of the HLA-DR and -DQ Molecules in the Multiple Sclerosis-Associated HLA-DR2 Haplotype
J. Immunol., February 1, 2006; 176(3): 1951 - 1961.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. S. Voo, G. Peng, Z. Guo, T. Fu, Y. Li, L. Frappier, and R.-F. Wang
Functional Characterization of EBV-Encoded Nuclear Antigen 1-Specific CD4+ Helper and Regulatory T Cells Elicited by In vitro Peptide Stimulation
Cancer Res., February 15, 2005; 65(4): 1577 - 1586.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Maccalli, Y. F. Li, M. El-Gamil, S. A. Rosenberg, and P. F. Robbins
Identification of a Colorectal Tumor-Associated Antigen (COA-1) Recognized by CD4+ T Lymphocytes
Cancer Res., October 15, 2003; 63(20): 6735 - 6743.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
D.-G. Lim, J. M. Slavik, K. Bourcier, K. J. Smith, and D. A. Hafler
Allelic Variation of MHC Structure Alters Peptide Ligands to Induce Atypical Partial Agonistic CD8+ T Cell Function
J. Exp. Med., July 7, 2003; 198(1): 99 - 109.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Z. Wang, R. Turner, B. M. Baker, and W. E. Biddison
MHC Allele-Specific Molecular Features Determine Peptide/HLA-A2 Conformations That Are Recognized by HLA-A2-Restricted T Cell Receptors
J. Immunol., September 15, 2002; 169(6): 3146 - 3154.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. A. Gebe, E. J. Novak, W. W. Kwok, A. G. Farr, G. T. Nepom, and J. H. Buckner
T Cell Selection and Differential Activation on Structurally Related HLA-DR4 Ligands
J. Immunol., September 15, 2001; 167(6): 3250 - 3256.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. K. Joshi, P. R. Suresh, and V. S. Chauhan
Flexibility in MHC and TCR Recognition: Degenerate Specificity at the T Cell Level in the Recognition of Promiscuous Th Epitopes Exhibiting No Primary Sequence Homology
J. Immunol., June 1, 2001; 166(11): 6693 - 6703.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. G. Doherty, S. Norris, L. Madrigal-Estebas, G. McEntee, O. Traynor, J. E. Hegarty, and C. O'Farrelly
The Human Liver Contains Multiple Populations of NK Cells, T Cells, and CD3+CD56+ Natural T Cells with Distinct Cytotoxic Activities and Th1, Th2, and Th0 Cytokine Secretion Patterns
J. Immunol., August 15, 1999; 163(4): 2314 - 2321.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.